An evaluation of the role of insulin-like growth factors (IGF) and of type-I IGF receptor signalling in hepatocarcinogenesis and in the resistance of hepatocarcinoma cells against drug-induced apoptosis
- 27 July 2004
- journal article
- review article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 68 (6), 1003-1015
- https://doi.org/10.1016/j.bcp.2004.05.029
Abstract
No abstract availableKeywords
This publication has 149 references indexed in Scilit:
- Serum insulin‐like growth factor I evaluation as a useful tool for predicting the risk of developing hepatocellular carcinoma in patients with hepatitis C virus‐related cirrhosisCancer, 2002
- Activation of the IGF-II Gene by HBV-X Protein Requires PKC and p44/p42 Map Kinase SignalingsBiochemical and Biophysical Research Communications, 2001
- Insulin and IGF-1 stimulate the β-catenin pathway through two signalling cascades involving GSK-3β inhibition and Ras activationOncogene, 2001
- The Hallmarks of CancerCell, 2000
- A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicinBiochemical Pharmacology, 1999
- Negative Regulation of PKB/Akt-Dependent Cell Survival by the Tumor Suppressor PTENCell, 1998
- Hepatocarcinogenesis in woodchuck hepatitis virus/c- myc mice: Sustained cell proliferation and biphasic activation of insulin-like growth factor IIHepatology, 1997
- Persistent Activation of c-Jun N-terminal Kinase 1 (JNK1) in γ Radiation-induced ApoptosisJournal of Biological Chemistry, 1996
- Cloning and increased expression of an insulin receptor substrate - 1-like gene in human hepatocellular carcinomaBiochemical and Biophysical Research Communications, 1992
- Evidence of autocrine regulation in human hepatoma cell linesBiochemical and Biophysical Research Communications, 1988